4-Phenylbutyric Acid
The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Triamcinolone.
Acarbose
The therapeutic efficacy of Acarbose can be decreased when used in combination with Triamcinolone.
Aceclofenac
The risk or severity of adverse effects can be increased when Aceclofenac is combined with Triamcinolone.
Advertisement
Acemetacin
The risk or severity of adverse effects can be increased when Acemetacin is combined with Triamcinolone.
Acetohexamide
The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Triamcinolone.
Acetyl salicylate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Triamcinolone.
Advertisement
Adapalene
The risk or severity of adverse effects can be increased when Adapalene is combined with Triamcinolone.
Aldesleukin
Triamcinolone may decrease the antineoplastic activities of Aldesleukin.
Alminoprofen
The risk or severity of adverse effects can be increased when Alminoprofen is combined with Triamcinolone.
Advertisement
Alogliptin
The therapeutic efficacy of Alogliptin can be decreased when used in combination with Triamcinolone.
Aloxiprin
The risk or severity of adverse effects can be increased when Aloxiprin is combined with Triamcinolone.
Aluminum
The bioavailability of Triamcinolone can be decreased when combined with Aluminium.
Aluminum Hydroxide
The bioavailability of Triamcinolone can be decreased when combined with Aluminum hydroxide.
aluminum hydroxide, dried (USP)
The bioavailability of Triamcinolone can be decreased when combined with Aluminum hydroxide.
Aluminum Magnesium Silicate
The bioavailability of Triamcinolone can be decreased when combined with Almasilate.
Ambenonium
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Ambenonium.
Aminosalicylic Acid
The risk or severity of adverse effects can be increased when Aminosalicylic Acid is combined with Triamcinolone.
Amiodarone
The metabolism of Triamcinolone can be decreased when combined with Amiodarone.
Amoxapine
The therapeutic efficacy of Triamcinolone can be decreased when used in combination with Amoxapine.
Amphotericin B
Triamcinolone may increase the hypokalemic activities of Amphotericin B.
amphotericin B liposomal
Triamcinolone may increase the hypokalemic activities of Amphotericin B.
Anhydrous Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Triamcinolone.
Anthrax immune globulin, human
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Anthrax immune globulin human.
Antipyrine
The risk or severity of adverse effects can be increased when Antipyrine is combined with Triamcinolone.
Apalutamide
The serum concentration of Triamcinolone can be decreased when it is combined with Apalutamide.
Apazone
The risk or severity of adverse effects can be increased when Azapropazone is combined with Triamcinolone.
Apremilast
The risk or severity of adverse effects can be increased when Apremilast is combined with Triamcinolone.
Aprepitant
The serum concentration of Triamcinolone can be increased when it is combined with Aprepitant.
Aspirin
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Triamcinolone.
Atazanavir
The metabolism of Triamcinolone can be decreased when combined with Atazanavir.
Atomoxetine
The metabolism of Triamcinolone can be decreased when combined with Atomoxetine.
Atracurium Besylate
Atracurium besylate may increase the adverse neuromuscular activities of Triamcinolone.
Azelastine
The risk or severity of adverse effects can be increased when Azelastine is combined with Triamcinolone.
Azosemide
Triamcinolone may increase the hypokalemic activities of Azosemide.
Balsalazide
The risk or severity of adverse effects can be increased when Balsalazide is combined with Triamcinolone.
BCG Vaccine
The risk or severity of adverse effects can be increased when Triamcinolone is combined with BCG vaccine.
BCG, Live, Connaught Strain
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Bacillus calmette-guerin substrain connaught live antigen.
BCG, Live, Tice Strain
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Bacillus calmette-guerin substrain tice live antigen.
Bendroflumethiazide
Triamcinolone may increase the hypokalemic activities of Bendroflumethiazide.
Benzoic Acid
The therapeutic efficacy of Benzoic Acid can be decreased when used in combination with Triamcinolone.
Benzydamine
The risk or severity of adverse effects can be increased when Benzydamine is combined with Triamcinolone.
Bismuth Subcitrate
The bioavailability of Triamcinolone can be decreased when combined with Bismuth Subcitrate.
Boceprevir
The metabolism of Triamcinolone can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Triamcinolone can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Triamcinolone can be decreased when it is combined with Bosentan.
Bromfenac
The risk or severity of adverse effects can be increased when Bromfenac is combined with Triamcinolone.
Bufexamac
The risk or severity of adverse effects can be increased when Bufexamac is combined with Triamcinolone.
Bumetanide
Triamcinolone may increase the hypokalemic activities of Bumetanide.
Calcitriol
The therapeutic efficacy of Calcitriol can be decreased when used in combination with Triamcinolone.
Calcium Carbonate
The bioavailability of Triamcinolone can be decreased when combined with Calcium Carbonate.
CALCIUM CARBONATE, PRECIPITATED
The bioavailability of Triamcinolone can be decreased when combined with Calcium Carbonate.
Canagliflozin
The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Triamcinolone.
Canagliflozin Anhydrous
The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Triamcinolone.
Capromab Pendetide
Triamcinolone may decrease effectiveness of Capromab pendetide as a diagnostic agent.
Carbamazepine
The metabolism of Triamcinolone can be increased when combined with Carbamazepine.
Carprofen
The risk or severity of adverse effects can be increased when Carprofen is combined with Triamcinolone.
Celecoxib
The risk or severity of adverse effects can be increased when Celecoxib is combined with Triamcinolone.
Ceritinib
The serum concentration of Triamcinolone can be increased when it is combined with Ceritinib.
Chloroquine
The risk or severity of adverse effects can be increased when Chloroquine is combined with Triamcinolone.
Chlorothiazide
Triamcinolone may increase the hypokalemic activities of Chlorothiazide.
Chlorotrianisene
The serum concentration of Triamcinolone can be increased when it is combined with Chlorotrianisene.
Chlorpropamide
The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Triamcinolone.
Chlorthalidone
Triamcinolone may increase the hypokalemic activities of Chlorthalidone.
Cholestyramine Resin
Cholestyramine can cause a decrease in the absorption of Triamcinolone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Choline Magnesium Trisalicyclate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Triamcinolone.
Cinoxacin
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Cinoxacin.
Clarithromycin
The metabolism of Triamcinolone can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Triamcinolone can be decreased when combined with Clemastine.
Clonixin
The risk or severity of adverse effects can be increased when Clonixin is combined with Triamcinolone.
Clotrimazole
The metabolism of Triamcinolone can be decreased when combined with Clotrimazole.
Cobicistat
The metabolism of Triamcinolone can be decreased when combined with Cobicistat.
Colesevelam
Colesevelam can cause a decrease in the absorption of Triamcinolone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Colestipol
Colestipol can cause a decrease in the absorption of Triamcinolone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Triamcinolone.
Corticorelin Ovine
The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Triamcinolone.
Corticorelin Ovine Triflutate
The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Triamcinolone.
Crizotinib
The metabolism of Triamcinolone can be decreased when combined with Crizotinib.
Curcumin
The risk or severity of adverse effects can be increased when Curcumin is combined with Triamcinolone.
Cyclopenthiazide
Triamcinolone may increase the hypokalemic activities of Cyclopenthiazide.
Cyclosporine
The metabolism of Triamcinolone can be decreased when combined with Cyclosporine.
Dabrafenib
The serum concentration of Triamcinolone can be decreased when it is combined with Dabrafenib.
Danazol
Triamcinolone may increase the fluid retaining activities of Danazol.
Darunavir
The metabolism of Triamcinolone can be decreased when combined with Darunavir.
Dasatinib
The serum concentration of Triamcinolone can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Triamcinolone can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Triamcinolone can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Triamcinolone can be decreased when combined with Delavirdine.
Demecarium
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Demecarium.
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Triamcinolone.
Diclofenac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Triamcinolone.
Dienestrol
The serum concentration of Triamcinolone can be increased when it is combined with Dienestrol.
Diethylstilbestrol
The serum concentration of Triamcinolone can be increased when it is combined with Diethylstilbestrol.
Diflunisal
The risk or severity of adverse effects can be increased when Diflunisal is combined with Triamcinolone.
Dihydroergotamine
The metabolism of Triamcinolone can be decreased when combined with Dihydroergotamine.
Diltiazem
The metabolism of Triamcinolone can be decreased when combined with Diltiazem.
Dipyrone
The risk or severity of adverse effects can be increased when Metamizole is combined with Triamcinolone.
Distigmine
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Distigmine.
Donepezil
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Donepezil.
Doxycycline
The metabolism of Triamcinolone can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Triamcinolone can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Triamcinolone can be decreased when combined with Dronedarone.
Droxicam
The risk or severity of adverse effects can be increased when Droxicam is combined with Triamcinolone.
Dulaglutide
The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Triamcinolone.
Echothiophate
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Echothiophate.
Edrophonium
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Edrophonium.
Empagliflozin
The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Triamcinolone.
Enoxacin
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Enoxacin.
Enzalutamide
The serum concentration of Triamcinolone can be decreased when it is combined with Enzalutamide.
Equol, (-)-
The serum concentration of Triamcinolone can be increased when it is combined with Equol.
Erythromycin
The metabolism of Triamcinolone can be decreased when combined with Erythromycin.
Estradiol
The serum concentration of Triamcinolone can be increased when it is combined with Estradiol.
Estradiol acetate
The serum concentration of Triamcinolone can be increased when it is combined with Estradiol acetate.
Estradiol Cypionate
The serum concentration of Triamcinolone can be increased when it is combined with Estradiol cypionate.
Estradiol Valerate
The serum concentration of Triamcinolone can be increased when it is combined with Estradiol valerate.
Estriol
The serum concentration of Triamcinolone can be increased when it is combined with Estriol.
Estrogens, Conjugated (USP)
The serum concentration of Triamcinolone can be increased when it is combined with Conjugated estrogens.
Estrogens, Esterified (USP)
The serum concentration of Triamcinolone can be increased when it is combined with Estrogens, esterified.
Estrone
The serum concentration of Triamcinolone can be increased when it is combined with Estrone.
Etanercept
The risk or severity of adverse effects can be increased when Etanercept is combined with Triamcinolone.
Ethacrynate
Triamcinolone may increase the hypokalemic activities of Etacrynic acid.
Ethacrynic Acid
Triamcinolone may increase the hypokalemic activities of Etacrynic acid.
Ethinyl Estradiol
The serum concentration of Triamcinolone can be increased when it is combined with Ethinyl Estradiol.
Etodolac
The risk or severity of adverse effects can be increased when Etodolac is combined with Triamcinolone.
Etofenamate
The risk or severity of adverse effects can be increased when Etofenamate is combined with Triamcinolone.
Etoricoxib
The risk or severity of adverse effects can be increased when Etoricoxib is combined with Triamcinolone.
Evening primrose oil
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Triamcinolone.
Exenatide
The therapeutic efficacy of Exenatide can be decreased when used in combination with Triamcinolone.
Felbinac
The risk or severity of adverse effects can be increased when Felbinac is combined with Triamcinolone.
Fenbufen
The risk or severity of adverse effects can be increased when Fenbufen is combined with Triamcinolone.
Fenoprofen
The risk or severity of adverse effects can be increased when Fenoprofen is combined with Triamcinolone.
Ferulic Acid
The risk or severity of adverse effects can be increased when Ferulic acid is combined with Triamcinolone.
Fingolimod
Triamcinolone may increase the immunosuppressive activities of Fingolimod.
Fleroxacin
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Fleroxacin.
Floctafenine
The risk or severity of adverse effects can be increased when Floctafenine is combined with Triamcinolone.
Fluconazole
The metabolism of Triamcinolone can be decreased when combined with Fluconazole.
Flumequine
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Flumequine.
Fluoxymesterone
Triamcinolone may increase the fluid retaining activities of Fluoxymesterone.
Flurbiprofen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Triamcinolone.
Fluvoxamine
The metabolism of Triamcinolone can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Triamcinolone can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Triamcinolone can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The metabolism of Triamcinolone can be increased when combined with Fosphenytoin.
Furosemide
Triamcinolone may increase the hypokalemic activities of Furosemide.
Fusidate
The serum concentration of Triamcinolone can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Triamcinolone can be increased when it is combined with Fusidic Acid.
Galantamine
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Galantamine.
Gallamine Triethiodide
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Gallamine Triethiodide.
Gatifloxacin
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Gatifloxacin.
Gatifloxacin Anhydrous
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Gatifloxacin.
Gemifloxacin
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Gemifloxacin.
Gemifloxacin Mesylate
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Gemifloxacin.
Genistein
The serum concentration of Triamcinolone can be increased when it is combined with Genistein.
Ginkgo biloba extract
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Ginkgo biloba.
Glibornuride
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Triamcinolone.
Gliclazide
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Triamcinolone.
Glimepiride
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Triamcinolone.
Glipizide
The therapeutic efficacy of Glipizide can be decreased when used in combination with Triamcinolone.
Gliquidone
The therapeutic efficacy of Gliquidone can be decreased when used in combination with Triamcinolone.
Glyburide
The therapeutic efficacy of Glyburide can be decreased when used in combination with Triamcinolone.
Glycerol Phenylbutyrate
The therapeutic efficacy of Glycerol Phenylbutyrate can be decreased when used in combination with Triamcinolone.
Grepafloxacin
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Grepafloxacin.
Hepatitis A Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Hepatitis A Vaccine.
Hepatitis B Surface Antigen Vaccine
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Hepatitis B Vaccine (Recombinant).
Hyaluronidase
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Triamcinolone.
Hyaluronidase, Ovine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Triamcinolone.
Hydrochlorothiazide
Triamcinolone may increase the hypokalemic activities of Hydrochlorothiazide.
Hydroflumethiazide
Triamcinolone may increase the hypokalemic activities of Hydroflumethiazide.
Hydrotalcite
The bioavailability of Triamcinolone can be decreased when combined with Hydrotalcite.
Hypoxis hemerocallidea root extract
The serum concentration of Triamcinolone can be decreased when it is combined with St. John's Wort.
Ibuprofen
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Triamcinolone.
Icatibant
The risk or severity of adverse effects can be increased when Icatibant is combined with Triamcinolone.
Idelalisib
The metabolism of Triamcinolone can be decreased when combined with Idelalisib.
Imatinib
The metabolism of Triamcinolone can be decreased when combined with Imatinib.
Indacaterol
Indacaterol may increase the hypokalemic activities of Triamcinolone.
Indapamide
Triamcinolone may increase the hypokalemic activities of Indapamide.
Indinavir
The metabolism of Triamcinolone can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Triamcinolone can be decreased when combined with Indinavir.
Indobufen
The risk or severity of adverse effects can be increased when Indobufen is combined with Triamcinolone.
Indomethacin
The risk or severity of adverse effects can be increased when Indomethacin is combined with Triamcinolone.
Insulin Detemir
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Triamcinolone.
Insulin Glargine
The therapeutic efficacy of Insulin Glargine can be decreased when used in combination with Triamcinolone.
insulin human, rDNA origin
The therapeutic efficacy of Insulin Human can be decreased when used in combination with Triamcinolone.
Insulin Lispro
The therapeutic efficacy of Insulin Lispro can be decreased when used in combination with Triamcinolone.
Insulin, Aspart Protamine, Human
The therapeutic efficacy of Insulin Aspart can be decreased when used in combination with Triamcinolone.
Insulin, Aspart, Human
The therapeutic efficacy of Insulin Aspart can be decreased when used in combination with Triamcinolone.
Insulin, Glulisine, Human
The therapeutic efficacy of Insulin Glulisine can be decreased when used in combination with Triamcinolone.
Insulin, Pork
The therapeutic efficacy of Insulin Pork can be decreased when used in combination with Triamcinolone.
Insulin, Protamine Lispro, Human
The therapeutic efficacy of Insulin Lispro can be decreased when used in combination with Triamcinolone.
Insulin, Regular, Pork
The therapeutic efficacy of Insulin Pork can be decreased when used in combination with Triamcinolone.
Isavuconazole
The serum concentration of Triamcinolone can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Triamcinolone can be decreased when combined with Isavuconazonium.
Isoflurophate
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Isoflurophate.
Isoniazid
The serum concentration of Isoniazid can be decreased when it is combined with Triamcinolone.
Isradipine
The metabolism of Triamcinolone can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Triamcinolone can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Triamcinolone can be increased when it is combined with Ivacaftor.
Kebuzone
The risk or severity of adverse effects can be increased when Kebuzone is combined with Triamcinolone.
Ketoconazole
The metabolism of Triamcinolone can be decreased when combined with Ketoconazole.
Ketoprofen
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Triamcinolone.
Ketorolac
The risk or severity of adverse effects can be increased when Ketorolac is combined with Triamcinolone.
Lacidipine
The serum concentration of Lacidipine can be decreased when it is combined with Triamcinolone.
Leflunomide
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Leflunomide.
Levofloxacin
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Levofloxacin.
Levofloxacin Anhydrous
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Levofloxacin.
Limonene, (+)-
The risk or severity of adverse effects can be increased when (4R)-limonene is combined with Triamcinolone.
Linagliptin
The therapeutic efficacy of Linagliptin can be decreased when used in combination with Triamcinolone.
Liraglutide
The therapeutic efficacy of Liraglutide can be decreased when used in combination with Triamcinolone.
Lopinavir
The metabolism of Triamcinolone can be decreased when combined with Lopinavir.
Lornoxicam
The risk or severity of adverse effects can be increased when Lornoxicam is combined with Triamcinolone.
Lovastatin
The metabolism of Triamcinolone can be decreased when combined with Lovastatin.
Loxoprofen
The risk or severity of adverse effects can be increased when Loxoprofen is combined with Triamcinolone.
Luliconazole
The serum concentration of Triamcinolone can be increased when it is combined with Luliconazole.
Lumacaftor
The metabolism of Triamcinolone can be increased when combined with Lumacaftor.
Magaldrate
The bioavailability of Triamcinolone can be decreased when combined with Magaldrate.
Magnesium Hydroxide
The bioavailability of Triamcinolone can be decreased when combined with Magnesium hydroxide.
Magnesium Oxide
The bioavailability of Triamcinolone can be decreased when combined with Magnesium oxide.
Magnesium Salicylate
The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Triamcinolone.
Magnesium Trisilicate
The bioavailability of Triamcinolone can be decreased when combined with Magnesium Trisilicate.
Malathion
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Malathion.
Masoprocol
The risk or severity of adverse effects can be increased when Masoprocol is combined with Triamcinolone.
Meclofenamate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Triamcinolone.
Meclofenamic Acid
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Triamcinolone.
Mefenamic Acid
The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Triamcinolone.
Mefloquine
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Mefloquine.
Meloxicam
The risk or severity of adverse effects can be increased when Meloxicam is combined with Triamcinolone.
Memantine
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Memantine.
Mesalamine
The risk or severity of adverse effects can be increased when Mesalazine is combined with Triamcinolone.
Mesterolone
Triamcinolone may increase the fluid retaining activities of Mesterolone.
Mestranol
The serum concentration of Triamcinolone can be increased when it is combined with Mestranol.
Metformin
The therapeutic efficacy of Metformin can be decreased when used in combination with Triamcinolone.
Methyclothiazide
Triamcinolone may increase the hypokalemic activities of Methyclothiazide.
Methyl Salicylate
The risk or severity of adverse effects can be increased when Methyl salicylate is combined with Triamcinolone.
Methyltestosterone
Triamcinolone may increase the fluid retaining activities of Methyltestosterone.
Metoclopramide
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Metoclopramide.
Metolazone
Triamcinolone may increase the hypokalemic activities of Metolazone.
Mifepristone
The therapeutic efficacy of Triamcinolone can be decreased when used in combination with Mifepristone.
Miglitol
The therapeutic efficacy of Miglitol can be decreased when used in combination with Triamcinolone.
Miglustat
The therapeutic efficacy of Miglustat can be decreased when used in combination with Triamcinolone.
Minaprine
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Minaprine.
Mitotane
The serum concentration of Triamcinolone can be decreased when it is combined with Mitotane.
Mivacurium
Mivacurium may increase the adverse neuromuscular activities of Triamcinolone.
MYCOPHENOLATE
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Triamcinolone.
Mycophenolate Mofetil
The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Triamcinolone.
Mycophenolic Acid
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Triamcinolone.
Nabumetone
The risk or severity of adverse effects can be increased when Nabumetone is combined with Triamcinolone.
Naftifine
The risk or severity of adverse effects can be increased when Naftifine is combined with Triamcinolone.
Nalidixic Acid
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Nalidixic Acid.
Nandrolone
Triamcinolone may increase the fluid retaining activities of Nandrolone.
Nandrolone Decanoate
Triamcinolone may increase the fluid retaining activities of Nandrolone decanoate.
Naproxen
The risk or severity of adverse effects can be increased when Naproxen is combined with Triamcinolone.
Natalizumab
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Natalizumab.
Nateglinide
The therapeutic efficacy of Nateglinide can be decreased when used in combination with Triamcinolone.
Nefazodone
The metabolism of Triamcinolone can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Triamcinolone can be decreased when combined with Nelfinavir.
Neostigmine
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Neostigmine.
Nepafenac
The risk or severity of adverse effects can be increased when Nepafenac is combined with Triamcinolone.
Netupitant
The serum concentration of Triamcinolone can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Triamcinolone can be increased when combined with Nevirapine.
Nicorandil
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Nicorandil.
Niflumic Acid
The risk or severity of adverse effects can be increased when Niflumic Acid is combined with Triamcinolone.
Nilotinib
The metabolism of Triamcinolone can be decreased when combined with Nilotinib.
Nimesulide
The risk or severity of adverse effects can be increased when Nimesulide is combined with Triamcinolone.
Norfloxacin
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Norfloxacin.
O-PHENANTHROLINE
The risk or severity of adverse effects can be increased when Triamcinolone is combined with 1,10-Phenanthroline.
Ocrelizumab
Ocrelizumab may increase the immunosuppressive activities of Triamcinolone.
Oenothera biennis seed extract
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Triamcinolone.
Olaparib
The metabolism of Triamcinolone can be decreased when combined with Olaparib.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Triamcinolone.
Olsalazine
The risk or severity of adverse effects can be increased when Olsalazine is combined with Triamcinolone.
Osimertinib
The serum concentration of Triamcinolone can be increased when it is combined with Osimertinib.
Oxandrolone
Triamcinolone may increase the fluid retaining activities of Oxandrolone.
Oxaprozin
The risk or severity of adverse effects can be increased when Oxaprozin is combined with Triamcinolone.
Oxymetholone
Triamcinolone may increase the fluid retaining activities of Oxymetholone.
Oxyphenbutazone
The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Triamcinolone.
Palbociclib
The serum concentration of Triamcinolone can be increased when it is combined with Palbociclib.
Parecoxib
The risk or severity of adverse effects can be increased when Parecoxib is combined with Triamcinolone.
Parthenolide
The risk or severity of adverse effects can be increased when Parthenolide is combined with Triamcinolone.
Pefloxacin
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Pefloxacin.
Pentobarbital
The metabolism of Triamcinolone can be increased when combined with Pentobarbital.
Phenformin
The therapeutic efficacy of Phenformin can be decreased when used in combination with Triamcinolone.
Phenobarbital
The metabolism of Triamcinolone can be increased when combined with Phenobarbital.
Phenylacetic Acid
The therapeutic efficacy of Phenylacetic acid can be decreased when used in combination with Triamcinolone.
Phenylbutazone
The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Triamcinolone.
Phenylbutyrate
The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Triamcinolone.
Phenytoin
The metabolism of Triamcinolone can be increased when combined with Phenytoin.
Physostigmine
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Physostigmine.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Triamcinolone.
Pioglitazone
The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Triamcinolone.
Piretanide
Triamcinolone may increase the hypokalemic activities of Piretanide.
Pirfenidone
The risk or severity of adverse effects can be increased when Pirfenidone is combined with Triamcinolone.
Piroxicam
The risk or severity of adverse effects can be increased when Piroxicam is combined with Triamcinolone.
Piroxicam-Beta-Cyclodextrin
The risk or severity of adverse effects can be increased when Piroxicam is combined with Triamcinolone.
Polyestradiol Phosphate
The serum concentration of Triamcinolone can be increased when it is combined with Polyestradiol phosphate.
Polythiazide
Triamcinolone may increase the hypokalemic activities of Polythiazide.
Posaconazole
The metabolism of Triamcinolone can be decreased when combined with Posaconazole.
Pramlintide
The therapeutic efficacy of Pramlintide can be decreased when used in combination with Triamcinolone.
Primidone
The metabolism of Triamcinolone can be increased when combined with Primidone.
Promestriene
The serum concentration of Triamcinolone can be increased when it is combined with Promestriene.
Pyridostigmine
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Pyridostigmine.
Pyridostigmine Bromide
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Pyridostigmine.
Quinestrol
The serum concentration of Triamcinolone can be increased when it is combined with Quinestrol.
Quinethazone
Triamcinolone may increase the hypokalemic activities of Quinethazone.
Rabies Immune Globulin, Human
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Human rabies virus immune globulin.
Rabies Virus Vaccine Flury-Lep Strain
The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Triamcinolone.
Ranolazine
The metabolism of Triamcinolone can be decreased when combined with Ranolazine.
Rapacuronium
Rapacuronium may increase the adverse neuromuscular activities of Triamcinolone.
Regular Insulin, Human
The therapeutic efficacy of Insulin Human can be decreased when used in combination with Triamcinolone.
Repaglinide
The therapeutic efficacy of Repaglinide can be decreased when used in combination with Triamcinolone.
Resveratrol
The risk or severity of adverse effects can be increased when Resveratrol is combined with Triamcinolone.
Rifabutin
The metabolism of Triamcinolone can be increased when combined with Rifabutin.
Rifampin
The metabolism of Triamcinolone can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Triamcinolone can be increased when combined with Rifapentine.
Ritonavir
The risk or severity of adverse effects can be increased when Ritonavir is combined with Triamcinolone.
Rivastigmine
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Rivastigmine.
Rofecoxib
The risk or severity of adverse effects can be increased when Rofecoxib is combined with Triamcinolone.
Roflumilast
Roflumilast may increase the immunosuppressive activities of Triamcinolone.
Rosiglitazone
The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Triamcinolone.
Rosoxacin
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Rosoxacin.
ROTAVIRUS VACCINE, LIVE
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Rotavirus Vaccine.
Rubella Virus Vaccine Live (wistar Ra 27-3 Strain)
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Rubella virus vaccine.
Rucaparib
The metabolism of Triamcinolone can be decreased when combined with Rucaparib.
Salicylamide
The risk or severity of adverse effects can be increased when Salicylamide is combined with Triamcinolone.
Salicylic Acid
The risk or severity of adverse effects can be increased when Salicylic acid is combined with Triamcinolone.
Salmonella enterica subsp. enterica serovar typhi
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Salmonella typhi ty21a live antigen.
Salsalate
The risk or severity of adverse effects can be increased when Salsalate is combined with Triamcinolone.
Saquinavir
The metabolism of Triamcinolone can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Triamcinolone can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Triamcinolone can be decreased when used in combination with Sarilumab.
Saxagliptin
The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Triamcinolone.
Saxagliptin Anhydrous
The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Triamcinolone.
Serratiopeptidase
The risk or severity of adverse effects can be increased when Serrapeptase is combined with Triamcinolone.
Sildenafil
The metabolism of Triamcinolone can be decreased when combined with Sildenafil.
Siltuximab
The serum concentration of Triamcinolone can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Triamcinolone can be increased when it is combined with Simeprevir.
sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Triamcinolone.
Sitagliptin
The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Triamcinolone.
Sitagliptin Phosphate
The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Triamcinolone.
Sodium Bicarbonate
The bioavailability of Triamcinolone can be decreased when combined with Sodium bicarbonate.
Sparfloxacin
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Sparfloxacin.
ST. JOHN'S WORT EXTRACT
The serum concentration of Triamcinolone can be decreased when it is combined with St. John's Wort.
Stanozolol
Triamcinolone may increase the fluid retaining activities of Stanozolol.
Sulfasalazine
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Triamcinolone.
Sulfisoxazole
The metabolism of Triamcinolone can be decreased when combined with Sulfisoxazole.
Sulindac
The risk or severity of adverse effects can be increased when Sulindac is combined with Triamcinolone.
Suprofen
The risk or severity of adverse effects can be increased when Suprofen is combined with Triamcinolone.
synthetic conjugated estrogens, A
The serum concentration of Triamcinolone can be increased when it is combined with Synthetic Conjugated Estrogens, A.
synthetic conjugated estrogens, B
The serum concentration of Triamcinolone can be increased when it is combined with Synthetic Conjugated Estrogens, B.
Tacrine
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Tacrine.
Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Triamcinolone.
Telaprevir
The serum concentration of Telaprevir can be decreased when it is combined with Triamcinolone.
Telithromycin
The metabolism of Triamcinolone can be decreased when combined with Telithromycin.
Temafloxacin
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Temafloxacin.
Tenoxicam
The risk or severity of adverse effects can be increased when Tenoxicam is combined with Triamcinolone.
Teriflunomide
The risk or severity of adverse effects can be increased when Teriflunomide is combined with Triamcinolone.
Testosterone
Triamcinolone may increase the fluid retaining activities of Testosterone.
Testosterone Cypionate
Triamcinolone may increase the fluid retaining activities of Testosterone cypionate.
Testosterone Enanthate
Triamcinolone may increase the fluid retaining activities of Testosterone enanthate.
Testosterone Propionate
Triamcinolone may increase the fluid retaining activities of Testosterone propionate.
Testosterone Undecanoate
Triamcinolone may increase the fluid retaining activities of Testosterone undecanoate.
Tetanus Toxoid Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Clostridium tetani toxoid antigen (formaldehyde inactivated).
Tiaprofenic Acid
The risk or severity of adverse effects can be increased when Tiaprofenic acid is combined with Triamcinolone.
Tibolone
The serum concentration of Triamcinolone can be increased when it is combined with Tibolone.
Ticlopidine
The metabolism of Triamcinolone can be decreased when combined with Ticlopidine.
Tocilizumab
The serum concentration of Triamcinolone can be decreased when it is combined with Tocilizumab.
Tofacitinib
Triamcinolone may increase the immunosuppressive activities of Tofacitinib.
Tolazamide
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Triamcinolone.
Tolbutamide
The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Triamcinolone.
Tolfenamic Acid
The risk or severity of adverse effects can be increased when Tolfenamic Acid is combined with Triamcinolone.
Tolmetin
The risk or severity of adverse effects can be increased when Tolmetin is combined with Triamcinolone.
Torsemide
Triamcinolone may increase the hypokalemic activities of Torasemide.
Tranilast
The risk or severity of adverse effects can be increased when Tranilast is combined with Triamcinolone.
Trastuzumab
Trastuzumab may increase the neutropenic activities of Triamcinolone.
Trichlormethiazide
Triamcinolone may increase the hypokalemic activities of Trichlormethiazide.
Troglitazone
The therapeutic efficacy of Troglitazone can be decreased when used in combination with Triamcinolone.
Trolamine Salicylate
The risk or severity of adverse effects can be increased when Trolamine salicylate is combined with Triamcinolone.
Tromethamine
The bioavailability of Triamcinolone can be decreased when combined with Tromethamine.
Trovafloxacin
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Trovafloxacin.
Tubocurarine
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Tubocurarine.
Typhoid Vaccine Live Ty21a
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Salmonella typhi ty21a live antigen.
Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Salmonella typhi ty2 vi polysaccharide antigen.
Valdecoxib
The risk or severity of adverse effects can be increased when Valdecoxib is combined with Triamcinolone.
Varicella Virus Vaccine Live (Oka-Merck) strain
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Varicella Zoster Vaccine (Live/Attenuated).
Vemurafenib
The serum concentration of Triamcinolone can be decreased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Triamcinolone can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Triamcinolone can be decreased when combined with Verapamil.
Vildagliptin
The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Triamcinolone.
Voriconazole
The metabolism of Triamcinolone can be decreased when combined with Voriconazole.
Warfarin
Triamcinolone may increase the anticoagulant activities of Warfarin.
Yellow Fever Vaccine
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Yellow Fever Vaccine.
Yellow-Fever Virus Vaccine, 17D-204 strain
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Yellow Fever Vaccine.
Zileuton
The risk or severity of adverse effects can be increased when Zileuton is combined with Triamcinolone.
Ziprasidone
The metabolism of Triamcinolone can be decreased when combined with Ziprasidone.
Zomepirac
The risk or severity of adverse effects can be increased when Zomepirac is combined with Triamcinolone.
